Single-cell dissection of chronic lung allograft dysfunction reveals convergent and distinct fibrotic mechanisms
Evidence level: single-cell transcriptomic analysis of explanted lungs with cross-disease integration; abstract-only
A single-cell analysis of CLAD lungs integrated with data from other fibrotic lung diseases, reporting CLAD-specific cell subsets and a shared KRT17-positive, KRT5-negative cell population.
As of . Primary source: Publisher record via DOI.
Summary
The abstract describes a single-cell transcriptomic analysis of CLAD lungs that combined newly generated datasets with about 1.6 million cells from 15 published studies of other fibrotic lung diseases. The authors report CLAD-specific cell subsets, namely Fibro.AT2 cells, exhausted CD8 T cells and superactivated macrophages, and suggest that KRT17-positive, KRT5-negative cells represent a common fibrotic mechanism across fibrotic lung diseases. A donor and recipient cell deconvolution found that recipient-derived stromal and immune cells showed stronger pro-fibrotic and allograft rejection pathways than donor-derived counterparts. The authors present this as a molecular framework and a source of potential therapeutic targets. The numbers of patients are not stated in the abstract.
Details
- doi
- 10.1172/jci.insight.197579
- pmid
- 41122970
- authors
- Yan Y, Kaihou T, Lecuona E, Wu X, Shigemura M, Sun H, Kurihara C, Gao R, Nunez-Santana FL, Budinger GS, Bharat A
- journal
- JCI Insight
- year
- 2025
- volume
- 10
- issue
- 20
- articleNumber
- e197579
Sources and links
- Publisher record via DOI (primary)
- PubMed 41122970
Related
Links from this record
- related to: Cytotoxic and senescent T cells
- related to: Innate immune activation
- related to: Airway transcriptomic signatures
Known gaps in this record
- full text not read (abstract only)
- funding statement and grant numbers
- author affiliations
- centre or centres not stated in the abstract
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.